Altered glucose metabolism in the hippocampal head in memory impairment

Neurology

Volumn 51, Issue 1, 1998, Pages 136-142

  Ouchi, Yasuomi ^b   Nobezawa, S ^c   Okada, H ^a   Yoshikawa, E ^a   Futatsubashi, M ^a   Kaneko, M ^c  

^a CENTRAL RESEARCH LABORATORY   (Japan)

^b Positron Medical Center   (Japan)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMNESIA; AMYGDALOID NUCLEUS; ARTICLE; BRAIN METABOLISM; CHILD; CLINICAL ARTICLE; FEMALE; GLUCOSE METABOLISM; HIPPOCAMPUS; HUMAN; IMAGE ANALYSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

EID: 0031843530     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.51.1.136     Document Type: Article

References (48)

1. Zola-Morgan S, Squire LR, Amaral DG. Human amnesia and the medial temporal region: enduring memory impairment following a bilateral lesion limited to field CA1 of the hippocampus. J Neurosci 1986;6:2950-2967.
2. Zola-Morgan S, Squire LR, Amaral DG, Suzuki WA. Lesions of perirhinal and parahippocampal cortex that spare the amygdala and hippocampal formation produce severe memory impairment. J Neurosci 1989;9:4355-4370.
3. Squire LR. Mechanisms of memory. Science 1986;232:1612-1619.
4. Fukuyama H, Harada K, Yamauchi H, et al. Coronal reconstruction images of glucose metabolism in Alzheimer's disease. J Neurol Sci 1991;106:128-134.
5. Ishii K, Kitagaki H, Kono M, Mori E. Decreased medial temporal oxygen metabolism in Alzheimer's disease shown by PET. J Nucl Med 1996;37:1159-1165.
6. 11C-deoxyglucose accumulation, CSF monoamine metabolites and neuropsychological test performance in patients and healthy subjects. J Neurol Neurosurg Psychiatry 1991;54:672-678.
7. Terry RD, Katzman R. Senile dementia of the Alzheimer type. Ann Neurol 1983;14:497-506.
8. Newman SK, Warrington EK, Kennedy AM, Rossor MN. The earliest cognitive change in a person with familial Alzheimer's disease: presymptomatic neuropsychological features in a pedigree with familial Alzheimer's disease confirmed at necropsy. J Neurol Neurosurg Psychiatry 1994;57:967-972.
9. Soininen HS, Partanen K, Pitkänen A, et al. Volumetric MRI analysis of the amygdala and the hippocampus in subjects with age-associated memory impairment. Neurology 1994;44: 1660-1668.
10. Mishkin M. Memory in monkeys severely impaired by combined but not by separate removal of amygdala and hippocampus. Nature 1978;273:297-298.
11. Duyckaerts C, Derouesne C, Signoret JL, et al. Bilateral and limited amygdalohippocampal lesions causing a pure amnesic syndrome. Ann Neurol 1985;18:314-319.
12. Duvernoy HM. The human hippocampus: an atlas of applied anatomy. New York: Springer-Verlag, 1988.
13. Hyman BT, Van Hoesen GW, Damasio AR. Memory-related neural systems in Alzheimer's disease: an anatomic study. Neurology 1990;40:1721-1730.
14. Kartsounis LD, Rudhe P, Stevens JM. Bilateral lesions of CA1 and CA2 fields of the hippocampus are sufficient to cause a severe amnesic syndrome in humans. J Neurol Neurosurg Psychiatry 1995;59:95-98.
15. Beaurain J, Dormont D, Semah F, et al. Hippocampal formations imaging with axial sections parallel to their longitudinal axis. Magn Reson Imaging 1994;12:139-148.
16. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Service Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
17. Berg L. Clinical dementia rating. Psychopharmacol Bull 1988; 24:637-639.
18. Wechsler D. The Wechsler Adult Intelligence Scale-Revised. San Antonio: Psychological Corporation, 1981.
19. Wechsler D. Wechsler Memory Scale-Revised. San Antonio: Psychological Corporation, 1987.
20. Mohs RC, Rosen WG, Davis KL. The Alzheimer's Disease Assessment Scale; an instrument for assessing treatment efficacy. Psychopharmacol Bull 1983;19:448-450.
21. Bronen RA, Cheung G. MRI of the normal hippocampus. Magn Reson Imaging 1991;9:497-500.
22. Ouchi Y, Nobesawa S, Okada H, et al. Glucose metabolism of the human hippocampal formation in the hippocampal long axis plane measured by PET. J Cereb Blood Flow Metab 1997; 17:S218. Abstract.
23. Yamashita T, Uchida H, Okada H, et al. Development of a high resolution PET. IEEE Trans Nucl Sci 1990;37:594-599.
24. Huang SC, Phelps ME, Hoffman EJ, et al. Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol 1980;238:E69-E82.
25. Baron JC, Miyazawa H. Use of positron emission tomography to assess effects of brain lesions in experiment subhuman primates. In: Michaelconn P, ed. Methods in neurosciences. San Diego: Academic Press, 1991:429-441.
26. Watson C, Andermann F, Gloor P, et al. Anatomic basis of amygdaloid and hippocampal volume measurement by magnetic resonance imaging. Neurology 1992;42:1743-1750.
27. Ouchi Y, Okada H, Kakiuchi T, et al. Co-registration between PET and MRI in rat brain. Ann Nucl Med 1996;10:S143. Abstract.
28. Duara R, Grady C, Haxby J, et al. Human brain glucose utilization and cognitive function in relation to age. Ann Neurol 1984;16:702-713.
29. Jagust WJ, Eberling JL, Richardson BC, et al. The cortical topography of temporal lobe hypometabolism in Alzheimer's disease. Brain Res 1993;629:189-198.
30. Frackowiak RS, Pozzilii C, Legg NJ, et al. Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography. Brain 1981;104:753-778.
31. Foster NL, Chase TN, Fedio P, et al. Alzheimer's disease: focal cortical changes shown by positron emission tomography. Neurology 1983;33:961-965.
32. Benson DF, Kuhl DE, Hawkins RA, et al. The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia. Arch Neurol 1983;40:711-714.
33. Minoshima S, Giordani B, Berent S, et al. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 1997;42:85-94.
34. Baulac M, Lehericy S, Chiras J. MR volumetric measurement of the hippocampal formation and amygdala in the mild stages of Alzheimer's disease. Neurology 1993;43:212. Letter.
35. Fazio F, Perani D, Gilardi MC, et al. Metabolic impairment in human amnesia: a PET study of memory networks. J Cereb Blood Flow Metab 1992;12:353-358.
36. Meltzer CC, Zubieta JK, Brandt J, et al. Regional hypometabolism in Alzheimer's disease as measured by positron emission tomography after correction for effects of partial volume averaging. Neurology 1996;47:454-461.
37. Hyman BT, Van Hoesen GW, Kromer LJ, Damasio AR. Perforant pathway changes and the memory impairment of Alzheimer's disease. Ann Neurol 1986;20:472-481.
38. Vanderwolf CH, Leung LW, Cooley RK. Pathway through cingulate, neo- and entorhinal cortices mediate atropine-resistant hippocampal rhythmical slow activity. Brain Res 1985;347:58-73.
39. Ridley RM, Timothy CJ, Maclean CJ, Baker HF. Conditional learning and memory impairments following neurotoxic lesion of the CA1 field of the hippocampus. Neuroscience 1995;67: 263-275.
40. Rempel-Clower NL, Zola-Morgan S, Squire LR, Amaral DG. Three cases of enduring memory impairment after bilateral damage limited to the hippocampal formation. J Neurosci 1996;16:5233-5255.
41. Van Hoesen GW, Hyman BT. Hippocampal formation: anatomy and the patterns of pathology in Alzheimer's disease. Prog Brain Res 1990;83:445-457.
42. Morris JS, Frith CD, Perrett DI, et al. A differential neural response in the human amygdala to fearful and happy facial expressions. Nature 1996;383:812-815.
43. Scott SK, Young AW, Calder AJ, et al. Impaired auditory recognition of fear and anger following bilateral amygdala lesions. Nature 1997;385:254-257.
44. Dicks D, Myers RE, Kling A. Uncus and amygdala lesions: effects on social behavior in the free ranging rhesus monkey. Science 1969;165:69-71.
45. Herzog AG, Kemper TL. Amygdala changes in aging and dementia. Arch Neurol 1980;37:625-629.
46. Herzog AG, Van Hoesen GW. Temporal neocortical afferent connections to the amygdala in the rhesus monkey. Brain Res 1976;115:57-69.
47. Cummings JL, Benson DF. Dementia of the Alzheimer's type: an inventory of diagnostic clinical features. J Am Geriatr Soc 1986;34:12-19.
48. Petry S, Cummings JL, Hill MA, Shapira J. Personality alterations in dementia of the Alzheimer type. Arch Neurol 1988; 45:1187-1190.